Skip to content

Latest

Medicine Chest buy brings CVS more Texas locations

CVS/pharmacy has acquired 19 of Medicine Chest’s 29 drug stores in Texas. Executives say the company will keep nine of the stores open and absorb the others into nearby existing CVS ­locations. Plans call for Medicine Chest to continue to operate its remaining 10 stores.

Senator goes to bat for more MTM coverage

North Carolina Sen. Kay Hagan continues to be hailed by community pharmacy advocates for her efforts to improve patient care. The National Association of Chain Drug Stores, for instance, recently cited the Democratic lawmaker for her continued leadership on behalf of pharmacy patient care.

PhRMA: What’s ahead for biopharmaceuticals in 2013?

It’s human nature to look ahead to the New Year. What will 2013 hold for America’s biopharmaceutical research sector? Well, quite a bit. John Castellani We will join other stakeholders in the dialogue over the role of health care costs in our nation’s economic challenges.

Wasson, Pessina are <i>CDR’s</i> Retailers of the Year

Wasson, Pessina are <i>CDR’s</i> Retailers of the Year

Striking a blockbuster deal that could shift the industry’s perspective, Walgreen Co. chief executive officer Greg Wasson and Alliance Boots executive chairman Stefano Pessina — and their management teams — have been selected as the 2012 Retailers of the Year by Chain Drug Review.

Watson cleared to release Lysteda generic

Watson Pharmaceuticals Inc. has received approval from the Food and Drug Administration for tranexamic acid tablets, a medication for menstrual bleeding. The company said Thursday that it will immediately begin shipping the product, which is a generic equivalent to Ferring Pharmaceuticals’ Lysteda.

December comp-store sales decrease at Walgreens

December comp-store sales decrease at Walgreens

Comparable-store sales at Walgreen Co. remained on the downside in December, as calendar day shifts and introductions of lower-price generic drugs impacted results. Walgreens said Friday that December same-store sales fell 6.1% from a year earlier. Calendar day shifts accounted for 1.

Unilever to divest Skippy peanut butter brand

Unilever has agreed to sell its global Skippy peanut butter business to Hormel Foods for about $700 million. The deal, announced Thursday, includes Unilever’s Skippy manufacturing facilities in Little Rock, Ark., and Weifang, China.